| Aurobindo Pharma Limited | 1,252 | 1,252G/0B | $0.6487 | -0.36% | 462↑ 561↓of 1023 | 4 | 18 |
| Sun Pharmaceutical Industries Inc. | 933 | 904G/29B | $3.1656 | -0.52% | 256↑ 313↓of 569 | 9 | 20 |
| NorthStar Rx LLC | 899 | 899G/0B | $1.6453 | -0.64% | 343↑ 502↓of 845 | 1 | 8 |
| Teva Pharmaceuticals USA Inc. | 812 | 795G/17B | $68.2250 | -0.93% | 304↑ 453↓of 757 | 5 | 13 |
| Rising Pharma Holdings Inc. | 764 | 763G/1B | $0.7495 | -0.46% | 320↑ 392↓of 712 | 1 | 7 |
| Major Pharmaceuticals | 734 | 734G/0B | $0.2937 | +0.09% | 344↑ 347↓of 691 | 23 | 7 |
| Dr. Reddy's Laboratories Inc. | 701 | 701G/0B | $2.2764 | -0.38% | 265↑ 312↓of 577 | 4 | 7 |
| Camber Pharmaceuticals Inc. | 668 | 668G/0B | $1.2922 | -0.89% | 247↑ 358↓of 605 | — | 7 |
| American Health Packaging | 639 | 638G/1B | $0.3724 | -0.16% | 278↑ 337↓of 615 | 35 | 2 |
| Mylan Pharmaceuticals Inc. | 628 | 623G/5B | $2.7794 | -0.68% | 291↑ 304↓of 595 | 7 | 7 |
| Zydus Pharmaceuticals (USA) Inc. | 625 | 618G/7B | $1.6000 | -0.50% | 259↑ 308↓of 567 | 2 | 8 |
| Lupin Pharmaceuticals Inc. | 557 | 552G/5B | $5.8175 | -0.45% | 207↑ 228↓of 435 | 2 | 13 |
| Alembic Pharmaceuticals Inc. | 523 | 523G/0B | $1.0480 | -0.67% | 224↑ 269↓of 493 | 2 | 2 |
| Chartwell RX LLC | 521 | 521G/0B | $0.5426 | -0.24% | 210↑ 286↓of 496 | 4 | 9 |
| Ascend Laboratories, LLC | 461 | 461G/0B | $1.2547 | -0.70% | 174↑ 226↓of 400 | — | 5 |
| Glenmark Pharmaceuticals Inc., USA | 444 | 444G/0B | $1.6038 | -1.15% | 149↑ 206↓of 355 | 2 | 8 |
| Actavis Pharma, Inc. | 439 | 438G/1B | $1.0783 | +0.01% | 186↑ 217↓of 403 | — | 11 |
| Strategic Sourcing Services LLC | 431 | 431G/0B | $0.2694 | +0.64% | 177↑ 133↓of 310 | 2 | 4 |
| Cardinal Health | 420 | 420G/0B | $0.1948 | +0.53% | 191↑ 148↓of 339 | 2 | 2 |
| Macleods Pharmaceuticals Limited | 418 | 418G/0B | $0.4919 | -0.24% | 192↑ 176↓of 368 | — | 1 |
| Hikma Pharmaceuticals USA Inc. | 414 | 414G/0B | $2.6443 | -0.92% | 131↑ 184↓of 315 | 2 | 3 |
| BluePoint Laboratories | 395 | 395G/0B | $2.8707 | +0.58% | 188↑ 153↓of 341 | 2 | 2 |
| Sandoz Inc. | 394 | 351G/43B | $22.3257 | -0.67% | 125↑ 185↓of 310 | 2 | 9 |
| AmerisourceBergen | 393 | 393G/0B | $0.3069 | +0.24% | 168↑ 164↓of 332 | 1 | 3 |
| Amneal Pharmaceuticals LLC | 388 | 359G/29B | $4.4038 | +0.33% | 141↑ 116↓of 257 | 2 | 15 |
| Solco Healthcare US LLC | 365 | 365G/0B | $0.2255 | +0.26% | 167↑ 179↓of 346 | 1 | 2 |
| Apotex Corp. | 362 | 350G/12B | $6.0600 | -1.21% | 124↑ 193↓of 317 | — | 10 |
| Heritage Pharmaceuticals Inc. | 317 | 317G/0B | $0.4786 | -0.30% | 120↑ 168↓of 288 | 2 | 7 |
| Accord Healthcare Inc. | 316 | 316G/0B | $0.7360 | -0.40% | 102↑ 123↓of 225 | 2 | 9 |
| Torrent Pharmaceuticals Limited | 315 | 315G/0B | $1.9880 | -0.26% | 120↑ 140↓of 260 | — | 2 |
| Cipla USA Inc. | 308 | 308G/0B | $1.7734 | -1.36% | 73↑ 132↓of 205 | 2 | 6 |
| Unichem Pharmaceuticals (USA) Inc. | 306 | 306G/0B | $0.1359 | +0.16% | 148↑ 134↓of 282 | — | 3 |
| Amneal Pharmaceuticals NY LLC | 306 | 306G/0B | $3.9831 | -1.34% | 104↑ 159↓of 263 | — | 7 |
| Upsher-Smith Laboratories LLC | 305 | 263G/42B | $3.2248 | -1.05% | 113↑ 140↓of 253 | — | 13 |
| AvPAK | 300 | 300G/0B | $0.2418 | +0.05% | 142↑ 153↓of 295 | 4 | 2 |
| ANI Pharmaceuticals, Inc. | 296 | 279G/17B | $3.1847 | -0.73% | 110↑ 151↓of 261 | 3 | 12 |
| Exelan Pharmaceuticals Inc. | 285 | 285G/0B | $0.2460 | -1.03% | 106↑ 156↓of 262 | — | — |
| Advagen Pharma Ltd. | 278 | 278G/0B | $0.4447 | -0.07% | 142↑ 134↓of 276 | — | 3 |
| Amneal Pharmaceuticals of New York LLC | 263 | 263G/0B | $3.1091 | +0.33% | 78↑ 69↓of 147 | — | 7 |
| Westminster Pharmaceuticals LLC | 263 | 263G/0B | $0.2950 | -0.40% | 112↑ 137↓of 249 | — | 1 |
| Padagis Israel Pharmaceuticals Ltd | 261 | 259G/2B | $3.3958 | +0.18% | 133↑ 111↓of 244 | — | 9 |
| Lannett Company Inc. | 258 | 258G/0B | $0.8108 | -0.34% | 102↑ 96↓of 198 | 2 | 5 |
| Strides Pharma Inc. | 247 | 247G/0B | $0.4603 | -0.40% | 114↑ 124↓of 238 | 2 | 3 |
| Epic Pharma LLC | 243 | 243G/0B | $0.4448 | -0.27% | 90↑ 109↓of 199 | 1 | 1 |
| Chain Drug Marketing Association | 227 | 227G/0B | $0.1224 | -0.15% | 66↑ 69↓of 135 | 5 | 3 |
| Endo USA Inc. | 219 | 204G/15B | $7.5621 | -0.71% | 83↑ 118↓of 201 | — | 8 |
| Granules Pharmaceuticals Inc. | 209 | 209G/0B | $0.6302 | -0.76% | 84↑ 111↓of 195 | — | 2 |
| Rugby Laboratories | 209 | 209G/0B | $0.4301 | +0.82% | 112↑ 81↓of 193 | 2 | 3 |
| Haleon US Holdings LLC | 203 | 0G/203B | $0.5315 | — | — | — | 8 |
| Ajanta Pharma USA Inc. | 194 | 194G/0B | $0.8920 | -0.09% | 81↑ 79↓of 160 | — | 5 |
| Novadoz Pharmaceuticals LLC | 191 | 191G/0B | $2.9825 | -2.34% | 72↑ 107↓of 179 | 3 | 2 |
| SpecGx LLC | 173 | 168G/5B | $1.6758 | -0.75% | 53↑ 108↓of 161 | — | 2 |
| L. Perrigo Company | 167 | 161G/6B | $0.2703 | +0.51% | 77↑ 81↓of 158 | — | 1 |
| Fresenius Kabi USA, LLC | 165 | 157G/8B | $24.9219 | -0.11% | 51↑ 45↓of 96 | — | 2 |
| Mylan Institutional LLC | 149 | 147G/2B | $25.1582 | -0.31% | 59↑ 63↓of 122 | 5 | 1 |
| Lifestar Pharma LLC | 148 | 148G/0B | $0.9734 | +0.12% | 60↑ 66↓of 126 | 2 | 2 |
| Quallent Pharmaceuticals Health LLC | 147 | 147G/0B | $4.5605 | -0.19% | 57↑ 88↓of 145 | 2 | 2 |
| Allergan, Inc. | 146 | 0G/146B | $40.6197 | +0.05% | 18↑ 21↓of 39 | — | 17 |
| Ingenus Pharmaceuticals LLC | 144 | 141G/3B | $3.6334 | -1.18% | 50↑ 76↓of 126 | 1 | 4 |
| Nivagen Pharmaceuticals Inc. | 137 | 137G/0B | $0.8433 | +0.03% | 31↑ 39↓of 70 | 1 | 5 |
| Viona Pharmaceuticals Inc. | 133 | 133G/0B | $0.5485 | -0.08% | 65↑ 67↓of 132 | — | 2 |
| Bionpharma Inc. | 131 | 131G/0B | $0.6423 | -1.11% | 47↑ 79↓of 126 | 2 | 1 |
| KVK-Tech Inc. | 130 | 130G/0B | $0.5363 | -0.05% | 35↑ 51↓of 86 | — | 5 |
| Cosette Pharmaceuticals, Inc. | 128 | 108G/20B | $4.0546 | -0.63% | 53↑ 54↓of 107 | — | 6 |
| Leading Pharma, LLC | 125 | 125G/0B | $0.9516 | -1.95% | 25↑ 80↓of 105 | 1 | 4 |
| ScieGen Pharmaceuticals, Inc. | 122 | 122G/0B | $0.1078 | +0.04% | 58↑ 61↓of 119 | — | 1 |
| Micro Labs Limited | 120 | 120G/0B | $0.8005 | -0.97% | 42↑ 60↓of 102 | 2 | 1 |
| Hospira Inc. | 119 | 117G/2B | $4.3185 | +0.88% | 34↑ 23↓of 57 | 2 | 3 |
| Jubilant Cadista Pharmaceuticals Inc. | 119 | 119G/0B | $0.2459 | -0.51% | 32↑ 36↓of 68 | — | 3 |
| Pfizer Inc. | 118 | 0G/118B | $62.7336 | -0.03% | 7↑ 7↓of 14 | — | 19 |
| RB Health (US) LLC | 110 | 0G/110B | $0.4154 | — | — | — | 4 |
| Method Pharmaceuticals LLC | 110 | 110G/0B | $0.2666 | +0.48% | 53↑ 40↓of 93 | — | 1 |
| Oceanside Pharmaceuticals | 108 | 108G/0B | $10.9894 | — | — | — | 4 |
| Bausch Health US LLC | 104 | 3G/101B | $34.0775 | — | — | — | 19 |
| Prasco Laboratories | 103 | 103G/0B | $16.0141 | -1.29% | 34↑ 63↓of 97 | — | 1 |
| Aurolife Pharma LLC | 99 | 99G/0B | $0.2474 | -1.56% | 20↑ 71↓of 91 | — | — |
| Taro Pharmaceuticals U.S.A. Inc. | 98 | 97G/1B | $0.9101 | -0.41% | 33↑ 31↓of 64 | — | 1 |
| Rhodes Pharmaceuticals L.P. | 97 | 83G/14B | $3.8940 | -0.48% | 24↑ 46↓of 70 | 1 | 1 |
| Viatris Specialty LLC | 95 | 4G/91B | $26.2217 | -0.17% | 6↑ 18↓of 24 | — | 21 |
| Slate Run Pharmaceuticals LLC | 94 | 94G/0B | $1.3541 | -0.48% | 36↑ 37↓of 73 | 1 | 1 |
| Alvogen Inc. | 94 | 94G/0B | $15.1437 | -0.50% | 41↑ 38↓of 79 | — | 2 |
| TruPharma LLC | 94 | 94G/0B | $1.0388 | +0.18% | 44↑ 35↓of 79 | — | 6 |
| Somerset Therapeutics, LLC | 93 | 93G/0B | $5.3589 | -1.30% | 27↑ 57↓of 84 | 1 | 1 |
| Biocon Pharma Inc. | 93 | 93G/0B | $2.5205 | -1.77% | 23↑ 60↓of 83 | — | 2 |
| Novartis Pharmaceuticals Corporation | 92 | 0G/92B | $762.79 | -0.09% | 4↑ 5↓of 9 | — | 15 |
| ScieGen Pharmaceuticals Inc. | 91 | 91G/0B | $0.2439 | -0.91% | 33↑ 56↓of 89 | — | — |
| Merck Sharp & Dohme LLC | 89 | 0G/89B | $84.7257 | -0.01% | 8↑ 27↓of 35 | — | 5 |
| Encube Ethicals, Inc. | 88 | 88G/0B | $0.8958 | +0.29% | 44↑ 40↓of 84 | — | — |
| AbbVie Inc. | 88 | 1G/87B | $1248.65 | — | 4↑ 4↓of 8 | — | 5 |
| Xiromed LLC | 88 | 88G/0B | $3.7060 | -1.05% | 32↑ 50↓of 82 | — | — |
| Time-Cap Labs Inc. | 86 | 86G/0B | $0.0732 | +0.72% | 41↑ 42↓of 83 | — | — |
| Bausch & Lomb Incorporated | 86 | 55G/31B | $21.6583 | -0.97% | 21↑ 32↓of 53 | 1 | 8 |
| Topco Associates LLC | 86 | 86G/0B | $0.3786 | — | — | 4 | 2 |
| Breckenridge Pharmaceutical Inc. | 85 | 85G/0B | $1.9081 | -0.59% | 23↑ 57↓of 80 | — | — |
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 82 | 82G/0B | $0.5726 | +0.38% | 37↑ 24↓of 61 | — | — |
| Oxford Pharmaceuticals, LLC | 82 | 82G/0B | $0.0743 | -0.62% | 32↑ 50↓of 82 | 1 | — |
| Takeda Pharmaceuticals America, Inc. | 80 | 1G/79B | $29.7739 | — | 11↑ 24↓of 35 | — | 14 |
| Mayne Pharma | 78 | 65G/13B | $33.6203 | -1.73% | 18↑ 26↓of 44 | 2 | 5 |
| Sagent Pharmaceuticals | 78 | 78G/0B | $6.6546 | -0.37% | 22↑ 19↓of 41 | — | — |
| Eli Lilly and Company | 77 | 4G/73B | $629.49 | -0.01% | 10↑ 6↓of 16 | — | 4 |
| Modavar Pharmaceuticals LLC | 75 | 75G/0B | $0.1491 | -0.31% | 31↑ 42↓of 73 | — | — |
| Boehringer Ingelheim Pharmaceuticals Inc. | 73 | 1G/72B | $69.6316 | — | 7↑ 15↓of 22 | — | 3 |
| Janssen Pharmaceuticals Inc. | 70 | 0G/70B | $580.60 | -0.02% | 4↑ 14↓of 18 | — | 5 |
| Padagis US LLC | 70 | 68G/2B | $7.7066 | -0.59% | 31↑ 29↓of 60 | — | 6 |
| Legacy Pharmaceutical Packaging, LLC | 68 | 68G/0B | $0.0449 | +0.90% | 36↑ 31↓of 67 | 3 | 2 |
| AstraZeneca Pharmaceuticals LP | 67 | 2G/65B | $38.5631 | -0.17% | 7↑ 20↓of 27 | — | 6 |
| GlaxoSmithKline LLC | 67 | 0G/67B | $34.6278 | -0.01% | 16↑ 20↓of 36 | — | 6 |
| Eugia US LLC | 67 | 67G/0B | $12.9025 | -0.99% | 18↑ 21↓of 39 | 1 | 1 |
| Meitheal Pharmaceuticals Inc. | 63 | 62G/1B | $23.4937 | -2.13% | 15↑ 29↓of 44 | — | — |
| Organon LLC | 62 | 1G/61B | $76.5794 | +0.01% | 9↑ 7↓of 16 | — | 14 |
| PAI Holdings LLC | 60 | 60G/0B | $4.3762 | -1.16% | 15↑ 34↓of 49 | 3 | 2 |
| PuraCap Laboratories LLC | 59 | 59G/0B | $0.6525 | +0.50% | 23↑ 23↓of 46 | — | — |
| Carlsbad Technology Inc. | 56 | 56G/0B | $0.1088 | -0.45% | 22↑ 28↓of 50 | — | — |
| Camber Consumer Care | 56 | 56G/0B | $0.1560 | -0.13% | 22↑ 31↓of 53 | — | — |
| Cranbury Pharmaceuticals, LLC | 56 | 56G/0B | $0.1716 | -0.01% | 26↑ 27↓of 53 | 1 | 1 |
| Novo Nordisk | 55 | 8G/47B | $182.05 | -0.02% | 7↑ 19↓of 26 | — | 2 |
| Pharmacia & Upjohn Company LLC | 55 | 0G/55B | $25.0253 | -0.24% | 3↑ 6↓of 9 | — | 10 |
| Sanofi-Aventis U.S. LLC | 54 | 17G/37B | $200.25 | -1.50% | 8↑ 12↓of 20 | — | 6 |
| Eywa Pharma Inc | 51 | 51G/0B | $0.4607 | -0.45% | 20↑ 31↓of 51 | — | — |
| McKesson | 50 | 50G/0B | $0.3432 | -0.59% | 6↑ 17↓of 23 | 3 | 1 |
| Laurus Labs Limited | 50 | 50G/0B | $0.3971 | -1.42% | 13↑ 33↓of 46 | — | — |
| Precision Dose Inc. | 48 | 48G/0B | $0.4020 | +0.38% | 20↑ 23↓of 43 | 1 | 1 |
| Alcon Laboratories, Inc. | 48 | 4G/44B | $12.1377 | +0.11% | 24↑ 11↓of 35 | — | 3 |
| Acella Pharmaceuticals, LLC | 48 | 48G/0B | $1.0607 | -0.96% | 15↑ 24↓of 39 | — | 2 |
| Florida Pharmaceutical Products, LLC | 48 | 48G/0B | $1.3420 | -0.55% | 12↑ 27↓of 39 | — | 1 |
| Bayer HealthCare LLC | 47 | 0G/47B | $0.5913 | — | — | — | 2 |
| Edenbridge Pharmaceuticals LLC | 46 | 46G/0B | $0.8434 | -0.63% | 17↑ 25↓of 42 | — | 1 |
| Elite Laboratories, Inc. | 46 | 46G/0B | $0.8260 | -0.56% | 18↑ 28↓of 46 | — | — |
| Trigen Laboratories, LLC | 45 | 45G/0B | $3.7179 | -1.79% | 15↑ 26↓of 41 | 1 | 2 |
| Quagen Pharmaceuticals LLC | 44 | 44G/0B | $0.3535 | -1.11% | 11↑ 29↓of 40 | — | — |
| Wilshire Pharmaceuticals Inc. | 42 | 42G/0B | $2.3886 | -2.72% | 17↑ 21↓of 38 | — | 1 |
| Par Health USA, LLC | 42 | 39G/3B | $3.8697 | -1.90% | 14↑ 22↓of 36 | — | 1 |
| Ohm Laboratories Inc. | 40 | 40G/0B | $0.2572 | +0.75% | 21↑ 13↓of 34 | — | 1 |
| Winder Laboratories LLC | 40 | 40G/0B | $0.9788 | -1.66% | 14↑ 23↓of 37 | — | — |
| Apnar Pharma LP | 37 | 37G/0B | $0.1407 | +0.21% | 17↑ 17↓of 34 | — | — |
| Mullan Pharmaceutical Inc. | 37 | 37G/0B | $1.8185 | +0.15% | 17↑ 18↓of 35 | — | 1 |
| UCB, Inc. | 37 | 0G/37B | $1008.76 | — | — | — | 3 |
| Sunrise Pharmaceutical Inc. | 37 | 37G/0B | $0.1751 | +0.30% | 13↑ 19↓of 32 | — | — |
| ACI Healthcare USA, Inc. | 36 | 36G/0B | $0.0623 | -0.31% | 12↑ 24↓of 36 | — | — |
| Baxter Healthcare Corporation | 35 | 35G/0B | $8.3495 | +3.08% | 10↑ 2↓of 12 | 1 | 1 |
| Vitruvias Therapeutics Inc. | 34 | 34G/0B | $2.6610 | -2.09% | 14↑ 16↓of 30 | — | — |
| Azurity Pharmaceuticals Inc. | 34 | 1G/33B | $5.7678 | -0.12% | 2↑ 6↓of 8 | 1 | 8 |
| Burel Pharmaceuticals, LLC | 33 | 33G/0B | $0.6672 | +0.13% | 15↑ 15↓of 30 | 1 | — |
| Amici Pharmaceuticals LLC | 32 | 32G/0B | $0.7088 | -1.43% | 12↑ 19↓of 31 | — | — |
| Amgen Inc. | 32 | 0G/32B | $875.70 | -0.04% | 1↑ 2↓of 3 | — | 1 |
| IBSA Pharma Inc. | 31 | 0G/31B | $5.3518 | — | — | — | 1 |
| Ritedose Pharmaceuticals, LLC | 30 | 30G/0B | $0.3528 | +0.17% | 15↑ 15↓of 30 | — | — |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 30 | 0G/30B | $10.5417 | -0.12% | 0↑ 8↓of 8 | — | 3 |
| TAGI Pharma Inc. | 29 | 29G/0B | $0.2435 | — | — | 1 | 1 |
| Civica, Inc. | 28 | 28G/0B | $3.4699 | +0.47% | 12↑ 4↓of 16 | — | — |
| Bayer HealthCare Pharmaceuticals Inc. | 28 | 0G/28B | $45.3709 | +0.04% | 6↑ 5↓of 11 | — | 2 |
| Otsuka America Pharmaceutical Inc. | 27 | 0G/27B | $721.09 | -0.11% | 0↑ 4↓of 4 | — | 2 |
| Novitium Pharma LLC | 27 | 27G/0B | $0.5197 | -0.36% | 12↑ 14↓of 26 | — | 1 |
| SOLA Pharmaceuticals LLC | 26 | 26G/0B | $1.0201 | -1.61% | 13↑ 12↓of 25 | — | — |
| Atlantis Consumer Healthcare, Inc. | 26 | 3G/23B | $0.2208 | +0.30% | 6↑ 13↓of 19 | — | 1 |
| Sigmapharm Laboratories LLC | 26 | 26G/0B | $3.2262 | +0.04% | 14↑ 11↓of 25 | 1 | — |
| Purdue Pharma LP | 25 | 0G/25B | $35.6209 | — | 2↑ 2↓of 4 | — | 1 |
| Galderma Laboratories, L.P. | 25 | 0G/25B | $11.3987 | +0.06% | 3↑ 0↓of 3 | — | 7 |
| Nephron Pharmaceuticals Corporation | 24 | 23G/1B | $0.2622 | +0.52% | 10↑ 9↓of 19 | 1 | — |
| Fosun Pharma USA Inc. | 24 | 24G/0B | $9.4973 | -0.37% | 7↑ 14↓of 21 | — | — |
| Ipca Laboratories Limited | 24 | 24G/0B | $0.0797 | -1.43% | 8↑ 16↓of 24 | — | — |
| Pacific Pharma, Inc. | 24 | 24G/0B | $5.9822 | -0.68% | 5↑ 17↓of 22 | — | 1 |
| E.R. Squibb & Sons, L.L.C. | 24 | 0G/24B | $178.01 | -0.13% | 1↑ 4↓of 5 | — | 3 |
| Noven Therapeutics, LLC | 23 | 5G/18B | $17.0314 | +0.79% | 8↑ 5↓of 13 | — | — |
| H2-Pharma LLC | 22 | 10G/12B | $25.3549 | +2.47% | 8↑ 9↓of 17 | 1 | 2 |
| Caplin Steriles Limited | 22 | 22G/0B | $2.7707 | -0.98% | 5↑ 13↓of 18 | — | 1 |
| Genus Lifesciences Inc. | 22 | 19G/3B | $1.5467 | -0.90% | 4↑ 11↓of 15 | — | 3 |
| Aarna USA Inc. | 21 | 21G/0B | $0.1263 | -0.96% | 8↑ 12↓of 20 | — | — |
| Almatica Pharma LLC | 21 | 7G/14B | $10.9001 | -1.22% | 3↑ 4↓of 7 | — | 8 |
| Devatis Inc. | 20 | 20G/0B | $6.0018 | -3.30% | 3↑ 10↓of 13 | — | — |
| American Regent, Inc. | 20 | 17G/3B | $8.4858 | +0.06% | 6↑ 5↓of 11 | — | 2 |
| WG Critical Care, LLC | 19 | 19G/0B | $6.9417 | -0.24% | 5↑ 2↓of 7 | — | 1 |
| Amphastar Pharmaceuticals, Inc. | 19 | 17G/2B | $84.4102 | -2.38% | 5↑ 10↓of 15 | — | — |
| Yiling Pharmaceutical Inc. | 19 | 19G/0B | $0.1560 | — | — | — | — |
| The Procter & Gamble Manufacturing Company | 18 | 0G/18B | $0.2947 | — | — | — | — |
| Astellas Pharma US, Inc. | 18 | 0G/18B | $17.5164 | -0.01% | 2↑ 3↓of 5 | — | 2 |
| Gilead Sciences, Inc. | 18 | 0G/18B | $285.99 | -0.05% | 0↑ 8↓of 8 | — | 2 |
| Oryza Pharmaceuticals Inc. | 18 | 18G/0B | $0.1338 | -0.74% | 4↑ 14↓of 18 | — | — |
| Neolpharma, Inc. | 17 | 17G/0B | $0.0603 | +1.22% | 15↑ 2↓of 17 | — | — |
| Reliable 1 Laboratories LLC | 17 | 17G/0B | $0.0268 | — | — | — | — |
| Vertical Pharmaceuticals, LLC | 17 | 3G/14B | $8.3186 | -1.06% | 2↑ 6↓of 8 | — | 2 |
| Amici Pharma, Inc | 16 | 16G/0B | $0.4245 | +2.09% | 12↑ 4↓of 16 | — | — |
| Tris Pharma Inc | 16 | 16G/0B | $0.4016 | +3.72% | 4↑ 2↓of 6 | — | 1 |
| Teva Neuroscience, Inc. | 16 | 0G/16B | $244.62 | +0.02% | 1↑ 0↓of 1 | — | 1 |
| Vensun Pharmaceuticals, Inc. | 15 | 15G/0B | $0.0549 | — | — | — | — |
| Seton Pharmaceuticals | 15 | 15G/0B | $21.3763 | -0.41% | 6↑ 3↓of 9 | — | — |
| Sumitomo Pharma America, Inc. | 15 | 0G/15B | $42.4662 | — | — | — | 2 |
| e5 Pharma, LLC | 15 | 15G/0B | $0.5686 | -2.11% | 5↑ 10↓of 15 | — | — |
| Eisai Inc. | 15 | 0G/15B | $22.1116 | +0.02% | 4↑ 3↓of 7 | — | 2 |
| Xellia Pharmaceuticals USA LLC | 15 | 15G/0B | $12.0048 | -1.07% | 1↑ 2↓of 3 | — | — |
| Genentech, Inc. | 15 | 0G/15B | $196.54 | -0.03% | 2↑ 5↓of 7 | — | 2 |
| Bausch & Lomb Americas Inc. | 15 | 15G/0B | $13.3498 | -1.87% | 5↑ 10↓of 15 | — | 1 |
| B. Braun Medical Inc. | 15 | 15G/0B | $0.0047 | +6.88% | 3↑ 0↓of 3 | — | — |
| Natco Pharma USA LLC | 15 | 15G/0B | $0.3265 | -1.81% | 4↑ 9↓of 13 | — | — |
| Neos Therapeutics Brands, LLC | 15 | 6G/9B | $16.8583 | +0.79% | 3↑ 12↓of 15 | — | 1 |
| Armas Pharmaceuticals Inc. | 15 | 15G/0B | $1.7135 | -2.11% | 1↑ 6↓of 7 | 1 | 1 |
| Trifluent Pharma LLC | 15 | 15G/0B | $6.1347 | +0.91% | 9↑ 4↓of 13 | — | 2 |
| Salix Pharmaceuticals Inc. | 15 | 0G/15B | $105.14 | — | — | — | 1 |
| Supernus Pharmaceuticals Inc. | 15 | 0G/15B | $19.9408 | -0.08% | 2↑ 5↓of 7 | — | 1 |
| Solaris Pharma Corporation | 14 | 14G/0B | $2.3333 | -1.60% | 5↑ 8↓of 13 | — | — |
| Xttrium Laboratories, Inc. | 14 | 10G/4B | $0.0527 | -0.14% | 6↑ 5↓of 11 | — | — |
| YARAL Pharma Inc. | 14 | 14G/0B | $2.6555 | — | — | — | — |
| Archis Pharma LLC | 14 | 14G/0B | $0.8238 | -0.73% | 7↑ 7↓of 14 | — | — |
| Saptalis Pharmaceuticals LLC | 13 | 11G/2B | $0.9790 | -1.50% | 5↑ 8↓of 13 | — | 1 |
| Provell Pharmaceuticals, LLC | 13 | 0G/13B | $0.1719 | — | — | — | — |
| Janssen Products LP | 13 | 0G/13B | $190.08 | +0.01% | 4↑ 2↓of 6 | — | 2 |
| Llorens Pharmaceutical International Division | 13 | 13G/0B | $0.0988 | -0.69% | 2↑ 4↓of 6 | — | — |
| BE Pharmaceuticals Inc. | 13 | 13G/0B | $10.9105 | -2.90% | 2↑ 5↓of 7 | — | — |
| ViiV Healthcare Company | 13 | 0G/13B | $60.6468 | — | — | — | 3 |
| NextWave Pharmaceuticals, Inc | 13 | 0G/13B | $8.9393 | — | 5↑ 2↓of 7 | — | 1 |
| Pharbest Pharmaceuticals, Inc. | 13 | 13G/0B | $0.0255 | — | — | — | — |
| Innogenix, Inc. | 13 | 13G/0B | $0.1626 | — | — | — | — |
| USAntibiotics, LLC | 13 | 13G/0B | $0.1800 | -0.24% | 5↑ 8↓of 13 | — | — |
| Collegium Pharmaceutical, Inc. | 13 | 0G/13B | $17.5109 | — | — | — | — |
| Afaxys Pharma, LLC | 13 | 13G/0B | $0.6170 | +0.81% | 8↑ 5↓of 13 | — | — |
| Patrin Pharma Inc. | 12 | 12G/0B | $0.4542 | -0.32% | 5↑ 5↓of 10 | 1 | 1 |
| Mission Pharmacal Company | 12 | 2G/10B | $4.3540 | -0.61% | 0↑ 3↓of 3 | — | 3 |
| Nordic Pharma, Inc. | 12 | 12G/0B | $5.8637 | -2.05% | 6↑ 6↓of 12 | — | — |
| i3 Pharmaceuticals, LLC | 12 | 12G/0B | $2.1152 | +0.64% | 7↑ 3↓of 10 | — | — |
| Roerig | 12 | 0G/12B | $23.0761 | -0.32% | 0↑ 2↓of 2 | — | 3 |
| Poly Pharmaceuticals, Inc. | 11 | 11G/0B | $0.5268 | -0.19% | 1↑ 1↓of 2 | — | — |
| C.B. Fleet Company, Inc. | 11 | 0G/11B | $0.0997 | +0.19% | 3↑ 1↓of 4 | — | 2 |
| Zameer Pharmaceuticals LLC | 11 | 11G/0B | $0.6900 | +0.92% | 1↑ 1↓of 2 | — | 3 |
| Crown Laboratories | 11 | 9G/2B | $0.2542 | — | — | — | 1 |
| CarWin Pharmaceutical Associates LLC | 11 | 2G/9B | $14.7229 | +5.13% | 2↑ 0↓of 2 | — | 3 |
| Larken Laboratories, Inc. | 11 | 11G/0B | $0.2209 | -1.15% | 3↑ 5↓of 8 | — | — |
| Edwards Pharmaceuticals, Inc. | 11 | 10G/1B | $0.8674 | +7.63% | 5↑ 2↓of 7 | — | — |
| Arbor Pharmaceuticals, Inc. | 11 | 11G/0B | $3.6116 | +5.31% | 2↑ 2↓of 4 | — | — |
| Novugen Pharma (USA) LLC | 11 | 11G/0B | $0.7260 | -3.56% | 4↑ 7↓of 11 | — | — |
| TWi Pharmaceuticals, Inc. | 11 | 11G/0B | $0.1383 | +0.40% | 7↑ 4↓of 11 | — | — |
| Aimmune Therapeutics, Inc. | 10 | 0G/10B | $8.5870 | — | — | — | — |
| Cambridge Therapeutics Technologies, LLC | 10 | 10G/0B | $0.2930 | — | — | — | 1 |
| Teva Parenteral Medicines, Inc. | 10 | 10G/0B | $2.8281 | +0.45% | 5↑ 3↓of 8 | — | 1 |
| Exeltis USA, Inc. | 10 | 0G/10B | $7.7904 | -0.02% | 0↑ 2↓of 2 | — | 1 |
| VistaPharm, LLC | 10 | 10G/0B | $0.8499 | -0.39% | 3↑ 5↓of 8 | 1 | 1 |
| Alkermes, Inc. | 10 | 0G/10B | $695.48 | — | — | — | — |
| Currax Pharmaceuticals LLC | 10 | 3G/7B | $24.6196 | — | — | — | 1 |
| Janssen Biotech, Inc. | 10 | 0G/10B | $13114.35 | — | — | — | 1 |
| CivicaScript LLC | 10 | 10G/0B | $0.9209 | -3.04% | 3↑ 6↓of 9 | — | — |
| SK Life Science, Inc. | 10 | 0G/10B | $35.2877 | — | — | — | — |
| Hepalink USA Inc. | 10 | 10G/0B | $7.5654 | -2.30% | 3↑ 6↓of 9 | — | — |
| Sheffield Pharmaceuticals LLC | 10 | 10G/0B | $0.1015 | +1.66% | 9↑ 1↓of 10 | — | — |
| EMD Serono, Inc. | 9 | 0G/9B | $1430.15 | -0.08% | 0↑ 1↓of 1 | — | — |
| Apozeal Pharmaceuticals Inc. | 9 | 9G/0B | $0.0459 | -0.76% | 4↑ 5↓of 9 | — | — |
| Axsome Therapeutics, Inc. | 9 | 0G/9B | $38.1186 | — | — | — | — |
| Carnegie Pharmaceuticals LLC | 9 | 7G/2B | $1.3243 | -0.60% | 4↑ 3↓of 7 | — | — |
| International Medication Systems, Limited | 9 | 9G/0B | $4.9296 | +0.52% | 3↑ 3↓of 6 | — | 1 |
| Virtus Pharmaceuticals, LLC | 9 | 9G/0B | $2.2303 | -2.62% | 2↑ 5↓of 7 | — | 2 |
| Person and Covey | 9 | 4G/5B | $0.0980 | +0.32% | 2↑ 0↓of 2 | — | — |
| XGen Pharmaceuticals DJB, Inc. | 9 | 9G/0B | $10.5517 | -0.68% | 3↑ 1↓of 4 | — | — |
| Nomax Inc. | 9 | 9G/0B | $0.4192 | -0.50% | 0↑ 9↓of 9 | — | — |
| Antares Pharma, Inc. | 9 | 0G/9B | $325.39 | -0.13% | 0↑ 1↓of 1 | — | 1 |
| Avet Pharmaceuticals Inc. | 9 | 9G/0B | $0.9618 | +0.16% | 3↑ 5↓of 8 | — | — |
| CMP Pharma, Inc. | 9 | 5G/4B | $2.4425 | +0.34% | 3↑ 2↓of 5 | 1 | 1 |
| Avion Pharmaceuticals, LLC | 9 | 0G/9B | $8.4339 | — | — | — | 1 |
| ARMAS PHARMACEUTICALS INC. | 9 | 9G/0B | $8.8525 | -2.55% | 2↑ 6↓of 8 | — | 1 |
| Gabar Health Sciences Corp. | 8 | 8G/0B | $0.2666 | — | — | 1 | — |
| Medimetriks Pharmaceuticals Inc. | 8 | 4G/4B | $40.8710 | +0.36% | 2↑ 2↓of 4 | — | 4 |
| Cephalon, LLC | 8 | 0G/8B | $47.2185 | +0.08% | 1↑ 0↓of 1 | — | 2 |
| Neurelis, Inc | 8 | 0G/8B | $366.24 | — | — | — | 1 |
| Avenacy Inc. | 8 | 8G/0B | $31.4523 | +0.56% | 5↑ 1↓of 6 | — | — |
| BioDelivery Sciences International Inc | 8 | 0G/8B | $14.1656 | — | — | — | — |
| Omnivium Pharmaceuticals LLC | 8 | 8G/0B | $1.9290 | +1.29% | 3↑ 0↓of 3 | — | 2 |
| Harrow Eye, LLC | 8 | 0G/8B | $90.0300 | -0.05% | 3↑ 3↓of 6 | — | 2 |
| Validus Pharmaceuticals LLC | 8 | 0G/8B | $2.5656 | +0.05% | 2↑ 1↓of 3 | — | 3 |
| Ferring Pharmaceuticals Inc. | 8 | 1G/7B | $167.32 | — | — | — | 1 |
| Teva Respiratory, LLC | 8 | 0G/8B | $131.30 | — | — | — | 2 |
| Medexus Pharma Inc. | 7 | 0G/7B | $542.66 | +2.58% | 6↑ 0↓of 6 | — | 1 |
| Fougera Pharmaceuticals Inc. | 7 | 7G/0B | $2.0296 | +0.44% | 2↑ 3↓of 5 | — | — |
| Catalyst Pharmaceuticals, Inc. | 7 | 0G/7B | $31.4231 | +0.02% | 3↑ 3↓of 6 | — | — |
| Indivior Inc. | 7 | 0G/7B | $703.00 | -0.05% | 1↑ 4↓of 5 | — | 1 |
| OWP Pharmaceuticals, Inc. | 7 | 7G/0B | $4.1560 | +1.64% | 5↑ 0↓of 5 | — | 1 |
| Daiichi Sankyo Inc. | 7 | 0G/7B | $14.3698 | -0.22% | 0↑ 1↓of 1 | — | 1 |
| Advanz Pharma (US) Corp. | 7 | 0G/7B | $12.8504 | — | — | — | 3 |
| U.S. Pharmaceutical Corporation | 7 | 0G/7B | $0.7320 | — | 3↑ 1↓of 4 | — | — |
| Sebela Pharmaceuticals Inc. | 7 | 0G/7B | $21.1074 | — | — | — | 1 |
| Santarus Inc. | 7 | 0G/7B | $81.9991 | — | — | — | 3 |
| Vanda Pharmaceuticals Inc. | 7 | 0G/7B | $41.0381 | — | — | — | — |
| Digestive Care, Inc. | 6 | 0G/6B | $5.3353 | — | — | — | — |
| Melinta Therapeutics, LLC | 6 | 0G/6B | $25.4004 | +0.03% | 2↑ 1↓of 3 | — | 1 |
| Mannkind Corporation | 6 | 0G/6B | $10.3321 | +2.95% | 5↑ 0↓of 5 | — | — |
| PureTek Corporation | 6 | 6G/0B | $0.8849 | -0.54% | 1↑ 1↓of 2 | — | — |
| Foundation Consumer Healthcare LLC | 6 | 4G/2B | $14.6070 | — | — | — | 1 |
| Thea Pharma Inc. | 6 | 0G/6B | $29.0914 | — | 3↑ 2↓of 5 | — | 3 |
| Xeris Pharmaceuticals, Inc. | 6 | 0G/6B | $1870.51 | — | — | — | — |
| Hisun Pharmaceuticals USA Inc. | 6 | 6G/0B | $1.6441 | -2.70% | 1↑ 3↓of 4 | 1 | — |
| BioComp Pharma Inc. | 6 | 6G/0B | $1.0168 | +0.65% | 3↑ 2↓of 5 | — | — |
| Orexo US, Inc. | 6 | 0G/6B | $11.4343 | — | — | — | — |
| Vivus LLC | 6 | 0G/6B | $5.2303 | — | — | — | — |
| Kesin Pharma Corporation | 6 | 5G/1B | $0.6282 | -2.39% | 0↑ 4↓of 4 | — | — |
| Allegis Pharmaceuticals, LLC | 6 | 6G/0B | $7.4490 | -0.28% | 3↑ 2↓of 5 | — | — |
| INA Pharmaceutics Inc | 5 | 4G/1B | $8.3335 | +3.32% | 2↑ 1↓of 3 | — | 1 |
| Coloplast Manufacturing US, LLC | 5 | 4G/1B | $0.0663 | — | — | — | — |
| Covis Pharma US, Inc | 5 | 0G/5B | $27.6491 | +0.07% | 2↑ 1↓of 3 | — | 1 |
| Brookfield Pharmaceuticals, LLC | 5 | 5G/0B | $0.4933 | — | — | — | — |
| Hikma Specialty USA Inc. | 5 | 0G/5B | $17.1099 | +0.23% | 3↑ 1↓of 4 | — | 1 |
| Biocon Biologics Inc. | 5 | 2G/3B | $649.94 | +0.01% | 2↑ 1↓of 3 | — | — |
| Ironshore Pharmaceuticals Inc. | 5 | 0G/5B | $15.4141 | — | — | — | 1 |
| LEO Pharma Inc. | 5 | 0G/5B | $17.6534 | -0.02% | 0↑ 2↓of 2 | — | 2 |
| Leadiant Biosciences, Inc. | 5 | 0G/5B | $0.6160 | — | — | — | — |
| Oliva Therapeutics, LLC | 5 | 4G/1B | $0.3841 | +6.18% | 4↑ 1↓of 5 | — | — |
| Patriot Pharmaceuticals | 5 | 5G/0B | $14.1826 | +1.43% | 1↑ 1↓of 2 | — | 1 |
| Pharmaceutical Associates, Inc. | 5 | 5G/0B | $0.1773 | -2.26% | 0↑ 2↓of 2 | — | — |
| Provepharm Inc. | 5 | 5G/0B | $24.9704 | — | — | — | — |
| Rising Health, LLC | 5 | 5G/0B | $0.0877 | -0.69% | 0↑ 5↓of 5 | — | — |
| The J. Molner Company LLC | 5 | 5G/0B | $0.6932 | -3.79% | 1↑ 3↓of 4 | — | 1 |
| VGYAAN Pharmaceuticals LLC | 5 | 5G/0B | $52.5815 | -0.66% | 0↑ 1↓of 1 | — | 1 |
| Immunex Corporation | 4 | 0G/4B | $2080.48 | — | — | — | — |
| Hillestad Pharmaceuticals USA | 4 | 4G/0B | $0.2465 | +0.19% | 2↑ 0↓of 2 | — | — |
| Oncor Pharmaceuticals | 4 | 4G/0B | $0.1456 | -1.59% | 1↑ 3↓of 4 | — | — |
| Acertis Pharmaceuticals, LLC | 4 | 2G/2B | $15.0467 | -0.06% | 1↑ 2↓of 3 | — | 2 |
| Braintree Laboratories, Inc. | 4 | 0G/4B | $17.1751 | -0.08% | 0↑ 3↓of 3 | — | — |
| Aprecia Pharmaceuticals, LLC | 4 | 0G/4B | $10.2726 | — | — | — | 1 |
| Medicure International Inc | 4 | 0G/4B | $7.4198 | -0.06% | 0↑ 2↓of 2 | — | — |
| GenBioPro, Inc. | 4 | 4G/0B | $0.6865 | +1.70% | 3↑ 0↓of 3 | — | — |
| Quinn Pharmaceuticals | 4 | 4G/0B | $0.1741 | -2.84% | 1↑ 3↓of 4 | — | — |
| GM Pharmaceuticals, INC | 4 | 1G/3B | $0.1799 | +0.69% | 1↑ 0↓of 1 | — | — |
| Fresenius Kabi, LLC | 4 | 4G/0B | $4.4165 | — | — | — | — |
| Phathom Pharmaceuticals Inc. | 4 | 0G/4B | $14.9700 | — | — | — | — |
| TOLMAR Inc. | 4 | 1G/3B | $9.0132 | -0.05% | 0↑ 1↓of 1 | — | — |
| Vista Pharmaceuticals, Inc. | 4 | 4G/0B | $0.0788 | — | — | — | 1 |
| Duchesnay USA, Inc. | 4 | 0G/4B | $7.2779 | -7.93% | 1↑ 1↓of 2 | — | 1 |
| Cameron Pharmaceuticals | 4 | 4G/0B | $1.3640 | +0.82% | 2↑ 2↓of 4 | — | — |
| Dista Products Company | 4 | 0G/4B | $16.4383 | — | — | — | 1 |
| Beach Products, Inc. | 4 | 4G/0B | $0.4189 | +2.87% | 2↑ 2↓of 4 | — | — |
| ACI Healthcare USA Inc. | 4 | 4G/0B | $0.0366 | +0.15% | 4↑ 0↓of 4 | — | — |
| SDA Laboratories, Inc. | 4 | 4G/0B | $0.0285 | — | — | — | — |
| Marnel Pharmaceuticals, Inc. | 3 | 3G/0B | $2.2079 | — | — | — | — |
| BF ASCHER AND CO INC | 3 | 1G/2B | $0.0589 | — | — | — | — |
| Lundbeck Pharmaceuticals LLC | 3 | 0G/3B | $34.0897 | -0.04% | 1↑ 2↓of 3 | — | 1 |
| Long Grove Pharmaceuticals, LLC | 3 | 3G/0B | $5.6679 | -1.18% | 2↑ 1↓of 3 | — | — |
| Vifor Pharma, Inc. | 3 | 0G/3B | $37.8047 | -0.04% | 0↑ 2↓of 2 | — | — |
| Lifsa Drugs LLC | 3 | 3G/0B | $9.9064 | -0.31% | 0↑ 1↓of 1 | — | 1 |
| Lexicon Pharmaceuticals, Inc. | 3 | 0G/3B | $20.1391 | — | — | — | — |
| Laser Pharmaceuticals, LLC | 3 | 3G/0B | $1.0092 | — | — | — | 1 |
| Intra-Cellular Therapies, Inc | 3 | 0G/3B | $57.3607 | — | — | — | — |
| WOMENS CHOICE PHARMACEUTICALS LLC | 3 | 1G/2B | $3.1567 | — | — | — | — |
| West-Ward Pharmaceuticals Corp | 3 | 3G/0B | $0.2997 | — | — | — | 1 |
| Greenstone LLC | 3 | 3G/0B | $0.8943 | -0.09% | 1↑ 2↓of 3 | — | — |
| Genzyme Corporation | 3 | 0G/3B | $13.3447 | -0.41% | 0↑ 1↓of 1 | — | 1 |
| GRIFOLS USA, LLC | 3 | 0G/3B | $3.5465 | — | — | — | — |
| ALK-Abello A S | 3 | 0G/3B | $11.7274 | — | — | — | — |
| CIMA LABS INC. | 3 | 3G/0B | $0.3159 | -1.87% | 0↑ 3↓of 3 | — | — |
| Cumberland Pharmaceuticals Inc. | 3 | 0G/3B | $236.14 | +3.00% | 1↑ 0↓of 1 | — | — |
| Savage Laboratories a division of Fougera Pharmaceuticals Inc. | 3 | 0G/3B | $1.6286 | +0.33% | 2↑ 0↓of 2 | — | — |
| CDMA | 3 | 3G/0B | $0.0132 | -1.28% | 2↑ 1↓of 3 | — | — |
| Royal Pharmaceuticals | 3 | 0G/3B | $0.5386 | -15.79% | 0↑ 3↓of 3 | — | — |
| RedHill Biopharma Ltd | 3 | 0G/3B | $11.3728 | — | — | — | — |
| Aquestive Therapeutics | 3 | 0G/3B | $38.1963 | +1.90% | 3↑ 0↓of 3 | — | 1 |
| Affordable Pharmaceuticals, LLC | 3 | 3G/0B | $0.0401 | -2.43% | 2↑ 1↓of 3 | — | — |
| Quest Products, LLC | 3 | 0G/3B | $0.3802 | +1.42% | 3↑ 0↓of 3 | — | 1 |
| Teva Women's Health, Inc. | 3 | 0G/3B | $36.2604 | — | — | — | 1 |
| Capital Pharma | 3 | 0G/3B | $0.2380 | — | — | — | — |
| Puro Pharma Inc. | 3 | 3G/0B | $0.9085 | -0.14% | 2↑ 1↓of 3 | — | 1 |
| Piramal Critical Care | 3 | 3G/0B | $1.3524 | — | — | — | — |
| kaleo, Inc | 3 | 0G/3B | $297.59 | -0.01% | 1↑ 2↓of 3 | — | — |
| Phlow Corporation | 3 | 3G/0B | $0.5095 | -0.27% | 1↑ 1↓of 2 | — | — |
| Arcutis Biotherapeutics, Inc. | 3 | 0G/3B | $15.3896 | — | — | — | 1 |
| OPKO Pharmaceuticals LLC | 3 | 0G/3B | $40.4386 | — | — | — | — |
| Aucta Pharmaceuticals, Inc. | 3 | 0G/3B | $21.2601 | — | — | — | 1 |
| Neurocrine Biosciences, Inc. | 3 | 0G/3B | $275.24 | — | — | — | — |
| Millicent US, Inc. | 3 | 0G/3B | $601.46 | — | — | — | — |
| Adare Pharmaceuticals Inc | 3 | 3G/0B | $0.1265 | — | — | — | — |
| Corium, LLC. | 3 | 0G/3B | $14.4452 | — | — | — | — |
| Valinor Pharma, LLC | 3 | 0G/3B | $14.6215 | — | — | — | — |